TCRT — Alaunos Therapeutics, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1107421 ·
Last close
$1.66
Market Cap
$4.22M
52W High
$4.50
52W Low
$0.72
ADV30
14,435,265
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -952,000 -952,000 1,516,000 124,000 864,000
Mar 2026 0 — -1,012,000 -1,006,000 1,883,000 354,000 595,000
Dec 2025 3,000 — -907,000 -893,000 2,966,000 1,385,000 813,000
Sep 2025 0 — -1,187,000 -1,159,000 3,724,000 1,938,000 921,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-2,727,000
Investing CF
$-1,000
Financing CF
$0
CapEx
$-1,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.18
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-926,580,000
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-4,058,000
Pretax Income TTM
$-4,010,000
Interest Exp TTM
—
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,000
EBITDA
$-4,034,000
Free Cash Flow
$-1,570,625
Enterprise Value
$3,712,124
Total Cash
$124,000
Total Debt
$0
Shares Out
2,540,480
Trailing EPS
$-1.75
Book Value
$0.54
ROE
-185.9%
ROA
-81.1%
Div Yield
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 5,000 -4,225,000 -4,176,000 2,966,000 813,000 2,153,000 -2,869,000
Dec 2024 10,000 -4,812,000 -4,679,000 2,755,000 692,000 2,063,000 -4,971,000
Dec 2023 5,000 -28,493,000 -35,140,000 8,263,000 1,956,000 6,307,000 -30,142,000
Dec 2022 2,922,000 -35,238,000 -37,730,000 64,937,000 26,382,000 38,555,000 -29,232,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$3,000
NetIncome TTM
$-4,010,000
OpCashFlow TTM
—
Assets (Latest)
$1,516,000
Forward EPS
$-0.60

Peers — same industry

TickerNameMarket CapLastDaily %
KPRX KIORA PHARMACEUTICALS INC $4.11M $0.93 —
RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. $4.02M $0.31 —
SKYE Skye Bioscience, Inc. $4.43M $1.00 —
ADXN Addex Therapeutics Ltd. $4.43M $3.50 —
SILO Silo Pharma, Inc. $4.00M $1.71 —

News headlines (Yahoo Finance, 1h cache)

Another Paragon spinout goes public through reverse merger
2026-10-13 20:35 · Yahoo
Top Midday Gainers
2026-10-13 17:50 · Yahoo
Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics
2026-10-13 14:31 · Yahoo
BC-Most Active Stocks
2026-10-13 14:30 · Yahoo
Paragon Labs Expands Leadership Team with Former Apogee Executives; Velaris Therapeutics Acquired by Alaunos Therapeutics, Inc.
2026-10-13 11:00 · Yahoo
Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study
2026-06-29 12:35 · Yahoo
Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies
2026-05-26 15:01 · Yahoo
Valion Bio Appoints Melinda Lackey as General Counsel
2026-05-04 20:05 · Yahoo
Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models
2026-05-18 12:00 · Yahoo
Alaunos Reports Positive Preclinical Obesity Drug Results Across Weight, Liver, Insulin Markers
2026-05-26 18:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.